Assignee
ZHEJIANG NANOMAB TECH CENTER CO LTD
CN·1 granted patent·4 pending applications·0 citations·filing 2020–2022
Top patents by PatentIndex Score
5 records- 0149US12442106B2Sequence-based high throughput method generating camelids antibodies to cover broad epitopes with high-resolutionZHEJIANG NANOMAB TECH CENTER CO LTD·Filed 2020·Granted Oct 14, 2025·0 cites·9 claims
- 0246US2024174760A1Nanobody targeting bcma and application thereofZHEJIANG NANOMAB TECH CENTER CO LTD·Filed 2022·Application pending·0 cites
- 0346US2025333508A1CTLA-4 Binding Molecule and Use ThereofZHEJIANG NANOMAB TECH CENTER CO LTD·Filed 2022·Application pending·0 cites
- 0445US2025215092A1Human Epidermal Growth Factor Receptor Binding Molecule and Use ThereofZHEJIANG NANOMAB TECH CENTER CO LTD·Filed 2022·Application pending·0 cites
- 0544US2024190986A1Mesothelin binding molecule and application thereofZHEJIANG NANOMAB TECH CENTER CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ZHEJIANG NANOMAB TECH CENTER CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →